HT
ACHN

HAP Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

HAP Trading’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-305,400
Closed -$24K – 1645
2019
Q4 		$24K Buy
+305,400
New +$1.77M ﹤0.01% 850
2018
Q4 		– Sell
-11,200
Closed -$5K – 1381
2018
Q3 		$5K Buy
+11,200
New +$33.4K ﹤0.01% 918
2015
Q4 		– Sell
-160,500
Closed -$1K – 1196
2015
Q3 		$1K Sell
160,500
-14,400
-8% -$117K ﹤0.01% 1027
2015
Q2 		$6K Buy
174,900
+24,900
+17% +$236K ﹤0.01% 890
2015
Q1 		$60K Sell
150,000
-1,191,600
-89% -$14.9M ﹤0.01% 602
2014
Q4 		$362K Buy
1,341,600
+236,400
+21% +$2.89M 0.01% 487
2014
Q3 		$664K Buy
1,105,200
+2,500
+0.2% +$23.2K 0.03% 419
2014
Q2 		$387K Buy
1,102,700
+2,700
+0.2% +$10.8K 0.01% 495
2014
Q1 		$138K Sell
1,100,000
-46,700
-4% -$163K 0.01% 660
2013
Q4 		$113K Buy
+1,146,700
New +$3.33M ﹤0.01% 787

HAP Trading's ACHN Position: Q1 2015 in Review

HAP Trading sold out of Achillion Pharmaceuticals (ACHN) in Q1 2015, closing a stake of 879,642 shares — an estimated $11M sold.

HAP Trading first reported a position in ACHN in Q2 2013 and held it in 7 quarters. The position peaked at $10.8M in Q4 2014. 173 funds tracked by Wall St. Rank hold ACHN as of Q1 2015.

  • HAP Trading reported no remaining Achillion Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • HAP Trading sold 879,642 Achillion Pharmaceuticals shares in Q1 2015, an estimated $11M.
  • HAP Trading first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • HAP Trading's Achillion Pharmaceuticals position peaked at $10.8M in Q4 2014.
  • 173 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2015.

Based on HAP Trading's 13F filing for Q1 2015, filed 13 May 2015.